Learn from Staci Stevens and 850+ other industry-leading experts.
Browse PlansStaci Stevens
MA
Staci Stevens holds a bachelor's degree in Sports Medicine and a master's degree in Exercise Physiology from the University of the Pacific in Stockton, California. Ms. Stevens, in conjunction with Workwell Foundation's research team, pioneered the use of two-day cardiopulmonary exercise testing (CPET) in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) to document the hallmark clinical feature of the illness, post-exertional malaise. She served on the Department of Health and Human Services's Chronic Fatigue Syndrome Advisory Committee and as vice president of the International Association of CFS/ME. Ms. Stevens co-authored a ME/CFS primer for clinical practitioners, ME International Consensus Criteria, and is a co-recipient of two publication awards from the California Physical Therapy Association for research in ME/CFS. Workwell is a collaborator with the National Institute of Health's (NIH) ME/CFS Intramural Study, NIH ME/CFS Collaborative Research Center, and a member of Cornell's Center for Innervating Neuroimmune Disease. Her clinical experience includes utilizing CPET for disability evaluation and activity management programs. She aims to functionally characterize ME/CFS, educate health care professionals, and improve quality of life for patients.
Courses with Staci Stevens
Browse Course CatalogME/CFS Part 1: Introduction and Identification
Presented by Todd E. Davenport, PT, DPT, MPH, OCS, Staci Stevens, MA, and Mark VanNess, PhD
ME/CFS Part 1: Introduction and Identification
Subscribe now, and access clinical education
and patient education—anytime, anywhere—with video instruction from
recognized industry experts.
This lesson is part one of a two-course series. Proceed to Part Two after completing this course.
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) causes severely disabling fatigue within the context of a constellation of unusual signs and symptoms, which are associated with over-exertion. Because people with ME/CFS present with a whole host of clinical findings, there are multiple reasons for entry into medical and rehabilitation settings. The multifactorial clinical presentation of ME/CFS emphasizes the need for clinicians to recognize ME/CFS, in order to advocate for patients/clients with possible ME/CFS and to direct its appropriate management. The pathoetiology of ME/CFS is becoming better understood, and there is emerging evidence based on this pathoetiological evidence to support best practices in analeptic management strategies for people with ME/CFS.
This two-part course series provides the opportunity for attendees to receive the latest information in recognition, etiology, and analeptic management of patients with ME/CFS from a panel of established researchers and clinicians. In this session, the presenters will (i) summarize the clinical features ME/CFS with respect to optimal identification and differential diagnosis; (ii) describe the pathoetiology underlying the clinical features of ME/CFS; and (iii) provide an actionable framework for optimal analeptic management of individuals with ME/CFS that is based on current scientific evidence.
ME/CFS Part 2: Etiology and Analeptic Management
Presented by Todd E. Davenport, PT, DPT, MPH, OCS, Staci Stevens, MA, and Mark VanNess, PhD
ME/CFS Part 2: Etiology and Analeptic Management
Subscribe now, and access clinical education
and patient education—anytime, anywhere—with video instruction from
recognized industry experts.
This lesson is the second part of the two-course series. Complete Part One before beginning this course.
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) causes severely disabling fatigue within the context of a constellation of unusual signs and symptoms, which are associated with overexertion. Because people with ME/CFS present with a whole host of clinical findings, there are multiple reasons for entry into medical and rehabilitation settings. The multifactorial clinical presentation of ME/CFS emphasizes the need for clinicians to recognize ME/CFS, in order to advocate for patients/clients with possible ME/CFS and to direct its appropriate management. The pathoetiology of ME/CFS is becoming better understood, and there is emerging evidence based on this pathoetiological evidence to support best practices in analeptic management strategies for people with ME/CFS.
This two-part course series provides the opportunity for attendees to receive the latest information in recognition, etiology, and analeptic management of patients with ME/CFS from a panel of established researchers and clinicians. In this session, the presenters will (i) summarize the clinical features ME/CFS with respect to optimal identification and differential diagnosis; (ii) describe the pathoetiology underlying the clinical features of ME/CFS; and (iii) provide an actionable framework for optimal analeptic management of individuals with ME/CFS that is based on current scientific evidence.
Start any course for free!
Get access to the first chapter of all 2600+ courses when you create a free account.
Sign Up for Free